(Q46085776)

19 December 2017

title

Is it cost-effective to treat recurrent hepatitis C infection in orthotopic liver transplantation patients? (English)

1 reference

19 December 2017

orthotopic liver transplantation

main subject

liver transplantation

1 reference

based on heuristic

inferred from title

1 reference

1 reference

7

Ronald W Busuttil

1 reference

19 December 2017

Sammy Saab

1

object named as

Sammy Saab

1 reference

19 December 2017

author name string

David Ly

2

1 reference

19 December 2017

Steven B Han

3

1 reference

19 December 2017

Robert K Lin

4

1 reference

19 December 2017

Sergio E Rojter

5

1 reference

19 December 2017

R Mark Ghobrial

6

1 reference

19 December 2017

publication date

1 May 2002

1 reference

19 December 2017

published in

Liver Transplantation

1 reference

19 December 2017

volume

8

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

449-457

1 reference

19 December 2017

Recurrent hepatitis C after liver transplantation: clinical and therapeutical issues

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Predictors of patient and graft survival following liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Hepatitis C viral infection in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Hepatitis C recurrence in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Therapy of hepatitis C: cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Long-term efficacy of treatment of chronic hepatitis C with alpha interferon or alpha interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.32717

21 January 2018

Identifiers

DOI

10.1053/JLTS.2002.32717

1 reference

19 December 2017

1 reference

19 December 2017